{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:49:37Z","timestamp":1793202577638,"version":"4.5.0"},"reference-count":495,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,12]],"date-time":"2027-02-12T00:00:00Z","timestamp":1802390400000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017618","name":"National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274165"],"award-info":[{"award-number":["82274165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82122074"],"award-info":[{"award-number":["82122074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20792"],"award-info":[{"award-number":["U24A20792"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.pharmr.2026.100115","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:52:02Z","timestamp":1768409522000},"page":"100115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases"],"prefix":"10.1016","volume":"78","author":[{"given":"Lili","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2685-6048","authenticated-orcid":false,"given":"Lihua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3735-9466","authenticated-orcid":false,"given":"Wendong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib1","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jhep.2025.06.010","article-title":"The history and future of bile acid therapies","volume":"83","author":"Beuers","year":"2025","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/nu2020116","article-title":"Dietary phospholipids and intestinal cholesterol absorption","volume":"2","author":"Cohn","year":"2010","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmr.2026.100115_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118182","article-title":"The bile acid-gut microbiota axis: a central hub for physiological regulation and a novel therapeutic target for metabolic diseases","volume":"188","author":"Zhao","year":"2025","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1124\/pharmrev.124.000978","article-title":"Bile acid signaling in metabolic and inflammatory diseases and drug development","volume":"76","author":"Li","year":"2024","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1194\/jlr.RA119000395","article-title":"Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition","volume":"61","author":"Honda","year":"2020","journal-title":"J Lipid Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib6","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/gbe\/evy243","article-title":"Loss of enzymes in the bile acid synthesis pathway explains differences in bile composition among mammals","volume":"10","author":"Sharma","year":"2018","journal-title":"Genome Biol Evol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.apsb.2023.11.011","article-title":"Mechanism of action of the bile acid receptor TGR5 in obesity","volume":"14","author":"Lun","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3350\/cmh.2022.0327","article-title":"Taurocholic acid promotes hepatic stellate cell activation via S1PR2\/p38 MAPK\/YAP signaling under cholestatic conditions","volume":"29","author":"Yang","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.pharmr.2026.100115_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.20517\/2394-4722.2016.05","article-title":"Muscarinic receptor signaling and colon cancer progression","volume":"2","author":"Xie","year":"2016","journal-title":"J Cancer Metastasis Treat"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.735","article-title":"Serum bile acids in liver cirrhosis promote neutrophil dysfunction","volume":"12","author":"Balazs","year":"2022","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.pharmr.2026.100115_bib12","article-title":"Research progress of bile acids in cancer","volume":"11","author":"Fu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.pharmr.2026.100115_bib13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejphar.2018.10.038","article-title":"An agonist of a zinc-sensing receptor GPR39 enhances tight junction assembly in intestinal epithelial cells via an AMPK-dependent mechanism","volume":"842","author":"Pongkorpsakol","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100115_bib14","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1016\/j.cell.2025.05.010","article-title":"A microbial amino-acid-conjugated bile acid, tryptophan-cholic acid, improves glucose homeostasis via the orphan receptor MRGPRE","volume":"188","author":"Lin","year":"2025","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.pharmr.2026.100115_bib15","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1016\/j.cell.2024.10.001","article-title":"Structure-guided discovery of bile acid derivatives for treating liver diseases without causing itch","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2026.100115_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48431","article-title":"MRGPRX4 is a bile acid receptor for human cholestatic itch","volume":"8","author":"Yu","year":"2019","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib17","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s12072-023-10636-4","article-title":"FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence","volume":"18","author":"Simbrunner","year":"2024","journal-title":"Hepatol Int"},{"issue":"5571","key":"10.1016\/j.pharmr.2026.100115_bib18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid sensor","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1124\/jpet.116.234096","article-title":"Pregnane X receptor activation attenuates inflammation-associated intestinal epithelial barrier dysfunction by inhibiting cytokine-induced myosin light-chain kinase expression and c-Jun N-terminal kinase 1\/2 activation","volume":"359","author":"Garg","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"7903","key":"10.1016\/j.pharmr.2026.100115_bib20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41586-022-04480-z","article-title":"Human gut bacteria produce \u03a4\u039717-modulating bile acid metabolites","volume":"603","author":"Paik","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2026.100115_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1147699","article-title":"Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: a narrow review","volume":"10","author":"Yang","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1446","article-title":"Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis","volume":"12","author":"Dragoljevic","year":"2023","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.pharmr.2026.100115_bib23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fphar.2020.01084","article-title":"Mechanism of hydrophobic bile acid-induced hepatocyte injury and drug discovery","volume":"11","author":"Wei","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100115_bib24","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.122","article-title":"Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells","volume":"1","author":"Goldberg","year":"2013","journal-title":"PeerJ"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5418","key":"10.1016\/j.pharmr.2026.100115_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bbadis.2010.11.011","article-title":"Regulation of FXR transcriptional activity in health and disease: emerging roles of FXR cofactors and post-translational modifications","volume":"1812","author":"Kemper","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1097-2765(00)00050-2","article-title":"Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors","volume":"6","author":"Lu","year":"2000","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib30","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3390\/ijms23116046","article-title":"Molecular basis of bile acid-FXR-FGF15\/19 signaling axis","volume":"23","author":"Katafuchi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"7916","key":"10.1016\/j.pharmr.2026.100115_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41586-022-04723-z","article-title":"Structural basis of sodium-dependent bile salt uptake into the liver","volume":"606","author":"Goutam","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib32","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/hep.31651","article-title":"Targeting the four pillars of enterohepatic bile salt cycling; lessons from genetics and pharmacology","volume":"73","author":"Kunst","year":"2021","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib33","first-page":"621","article-title":"FXR, a target for different diseases","volume":"23","author":"Wang","year":"2008","journal-title":"Histol Histopathol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib34","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI25604","article-title":"Farnesoid X receptor is essential for normal glucose homeostasis","volume":"116","author":"Ma","year":"2006","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib35","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib36","article-title":"Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implications","volume":"12","author":"Hu","year":"2024","journal-title":"Genes Dis"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib37","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1161\/CIRCRESAHA.121.320056","article-title":"Proprotein convertase subtilisin\/kexin 9 (PCSK9) promotes macrophage activation via LDL receptor-independent mechanisms","volume":"131","author":"Katsuki","year":"2022","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib38","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/CIRCRESAHA.112.300648","article-title":"MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor","volume":"112","author":"de Aguiar Vallim","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2026.100115_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jare.2024.06.027","article-title":"Anti-diabetic effect of dicaffeoylquinic acids is associated with the modulation of gut microbiota and bile acid metabolism","volume":"72","author":"Huang","year":"2025","journal-title":"J Adv Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib41","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib42","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","article-title":"Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis","volume":"25","author":"Hao","year":"2017","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41392-023-01727-7","article-title":"Hepatic Zbtb18 (zinc finger and BTB domain containing 18) alleviates hepatic steatohepatitis via FXR (farnesoid X receptor)","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib44","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"issue":"8049","key":"10.1016\/j.pharmr.2026.100115_bib46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41586-024-08379-9","article-title":"Host metabolism balances microbial regulation of bile acid signalling","volume":"638","author":"Won","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib48","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-023-41061-8","article-title":"Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPAR\u03b1 nucleus-cytoplasm shuttling","volume":"14","author":"Zhong","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2025.100265","article-title":"Microbiota-derived bile acid metabolic enzymes and their impacts on host health","volume":"4","author":"Ma","year":"2025","journal-title":"Cell Insight"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/cells11010061","article-title":"The nuclear receptor PXR in chronic liver disease","volume":"11","author":"Sayaf","year":"2021","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib52","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/hep.22907","article-title":"A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte","volume":"49","author":"Moreau","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2026.100115_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107779","article-title":"The intestinal functions of PXR and CAR","volume":"216","author":"Feng","year":"2025","journal-title":"Pharmacol Res"},{"issue":"44","key":"10.1016\/j.pharmr.2026.100115_bib54","doi-asserted-by":"crossref","first-page":"18831","DOI":"10.1073\/pnas.0909731106","article-title":"Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease","volume":"106","author":"Dong","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2026.100115_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108238","article-title":"Bile acid metabolism and signaling, the microbiota, and metabolic disease","volume":"237","author":"Cai","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib56","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1111\/bph.12090","article-title":"The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4\u03b1 and FOXO1 transcriptional activity","volume":"168","author":"Yarushkin","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib58","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3390\/cells11071129","article-title":"Vitamin D receptor influences intestinal barriers in health and disease","volume":"11","author":"Sun","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/imm.13672","article-title":"Effect of gut flora mediated-bile acid metabolism on intestinal immune microenvironment","volume":"170","author":"Zhang","year":"2023","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"7785","key":"10.1016\/j.pharmr.2026.100115_bib61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control TH17 and Treg cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib62","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.cell.2025.02.029","article-title":"Microbiota-derived bile acids antagonize the host androgen receptor and drive anti-tumor immunity","volume":"188","author":"Jin","year":"2025","journal-title":"Cell"},{"issue":"7915","key":"10.1016\/j.pharmr.2026.100115_bib63","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in T cells limits checkpoint blockade efficacy","volume":"606","author":"Guan","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib64","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab"},{"issue":"7075","key":"10.1016\/j.pharmr.2026.100115_bib65","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib66","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.gastro.2020.05.067","article-title":"Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration","volume":"159","author":"Sorrentino","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib67","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","article-title":"Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome","volume":"45","author":"Guo","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib68","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor \u03ba light-chain enhancer of activated B cells (NF-\u03baB) in mice","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100115_bib69","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.1903316116","article-title":"MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus","volume":"116","author":"Meixiong","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7887","key":"10.1016\/j.pharmr.2026.100115_bib70","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41586-021-04126-6","article-title":"Structure, function and pharmacology of human itch GPCRs","volume":"600","author":"Cao","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib71","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.tips.2023.02.002","article-title":"The structure, function, and pharmacology of MRGPRs","volume":"44","author":"Cao","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib72","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1210\/me.2007-0055","article-title":"GPR39 splice variants versus antisense gene LYPD1: expression and regulation in gastrointestinal tract, endocrine pancreas, liver, and white adipose tissue","volume":"21","author":"Egerod","year":"2007","journal-title":"Mol Endocrinol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj0146","article-title":"Discoveries of GPR39 as an evolutionarily conserved receptor for bile acids and of its involvement in biliary acute pancreatitis","volume":"10","author":"Zi","year":"2024","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib74","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.27592","article-title":"Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression","volume":"61","author":"Nagahashi","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib76","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.29076","article-title":"The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib77","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.pharmr.2026.100115_bib78","article-title":"Cholesterol and the gut-liver axis: unraveling their role in the onset and progression of metabolic-associated steatotic liver disease","volume":"4","author":"Rodr\u00edguez-Rojas","year":"2025","journal-title":"Explor Dig Dis"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib79","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/microorganisms10020452","article-title":"Dysbiotic gut bacteria in obesity: an overview of the metabolic mechanisms and therapeutic perspectives of next-generation probiotics","volume":"10","author":"Breton","year":"2022","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib80","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/nu12051474","article-title":"The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?","volume":"12","author":"Magne","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-0042-1748037","article-title":"Intestinal barrier dysfunction in fatty liver disease: roles of microbiota, mucosal immune system, and bile acids","volume":"42","author":"Gupta","year":"2022","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/metabo15060397","article-title":"Gut microbiota dysbiosis and its impact on type 2 diabetes: from pathogenesis to therapeutic strategies","volume":"15","author":"Yu","year":"2025","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib83","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s13679-023-00503-6","article-title":"Short-chain fatty acids-A product of the microbiome and its participation in two-way communication on the microbiome-host mammal line","volume":"12","author":"Lange","year":"2023","journal-title":"Curr Obes Rep"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib84","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3390\/nu13113839","article-title":"Intestinal microbiota as a contributor to chronic inflammation and its potential modifications","volume":"13","author":"Potrykus","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib85","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000481519","article-title":"Gut microbiota-dependent modulation of energy metabolism","volume":"10","author":"Heiss","year":"2018","journal-title":"J Innate Immun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","article-title":"The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health","volume":"13","author":"Nogal","year":"2021","journal-title":"Gut Microbes"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib87","article-title":"Gut dysbiosis and cardiovascular health: a comprehensive review of mechanisms and therapeutic potential","volume":"16","author":"Trehan","year":"2024","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib88","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-2275(20)41693-1","article-title":"Cholesterol 7 alpha-hydroxylase","volume":"18","author":"Myant","year":"1977","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharmr.2026.100115_bib89","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bcp.2019.04.008","article-title":"Advances in understanding the regulatory mechanism of cholesterol 7\u03b1-hydroxylase","volume":"164","author":"Ge","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib90","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","article-title":"Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis","volume":"4","author":"Chiang","year":"2020","journal-title":"Liver Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib91","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7\u03b1-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype","volume":"110","author":"Pullinger","year":"2002","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib92","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1194\/jlr.M064709","article-title":"Cholesterol 7\u03b1-hydroxylase-deficient mice are protected from high-fat\/high-cholesterol diet-induced metabolic disorders","volume":"57","author":"Ferrell","year":"2016","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib93","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1194\/jlr.M200489-JLR200","article-title":"Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice","volume":"44","author":"Erickson","year":"2003","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib94","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s11658-024-00673-8","article-title":"Maternal high-fat diet orchestrates offspring hepatic cholesterol metabolism via MEF2A hypermethylation-mediated CYP7A1 suppression","volume":"29","author":"Zhang","year":"2024","journal-title":"Cell Mol Biol Lett"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib95","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/biomedicines12030617","article-title":"Associations of the CYP7A1 gene polymorphisms located in the promoter and enhancer regions with the risk of acute coronary syndrome, plasma cholesterol, and the incidence of diabetes","volume":"12","author":"Vargas-Alarc\u00f3n","year":"2024","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib96","doi-asserted-by":"crossref","first-page":"822","DOI":"10.17305\/bb.2024.10764","article-title":"Cholesterol 7 alpha-hydroxylase (CYP7A1) gene polymorphisms are associated with increased LDL-cholesterol levels and the incidence of subclinical atherosclerosis","volume":"25","author":"Vargas-Alarc\u00f3n","year":"2025","journal-title":"Biomol Biomed"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib97","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/hq0102.102588","article-title":"Transgenic expression of cholesterol-7-\u03b1-hydroxylase prevents atherosclerosis in C57BL\/6J mice","volume":"22","author":"Miyake","year":"2002","journal-title":"Arterioscler Throm Vas"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib98","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/hep.24107","article-title":"Overexpression of cholesterol 7\u03b1-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis","volume":"53","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmr.2026.100115_bib99","article-title":"Pharmacological modulation of cholesterol 7\u03b1-hydroxylase as a therapeutic strategy for hypercholesterolemia","volume":"220","author":"Lim","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100115_bib100","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/eurheartj\/ehy068","article-title":"Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease","volume":"39","author":"Qayyum","year":"2018","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib101","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.23721","article-title":"Transgenic expression of cholesterol 7\u03b1-hydroxylase in the liver prevents high-fat diet induced obesity and insulin resistance in mice","volume":"52","author":"Li","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib102","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1074\/jbc.M111.305789","article-title":"Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity","volume":"287","author":"Li","year":"2012","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib103","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.2337\/db13-0639","article-title":"Human insulin resistance is associated with increased plasma levels of 12\u03b1-hydroxylated bile acids","volume":"62","author":"Haeusler","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmr.2026.100115_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108412","article-title":"Association between 12\u03b1-hydroxylated bile acids and hepatic steatosis in rats fed a high-fat diet","volume":"83","author":"Hori","year":"2020","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.pharmr.2026.100115_bib105","first-page":"843","article-title":"Association of CYP7A1 and CYP2E1 polymorphisms with type 2 diabetes in the Chinese Han populations","volume":"15","author":"Zhang","year":"2022","journal-title":"Pharmgenomics Pers Med"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib106","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1194\/jlr.M069807","article-title":"Cholesterol 7\u03b1-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis","volume":"57","author":"Liu","year":"2016","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib107","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3382\/ps.2010-01207","article-title":"Low-level expression of cholesterol 7\u03b1-hydroxylase is associated with the formation of goose fatty liver","volume":"90","author":"Zhao","year":"2011","journal-title":"Poult Sci"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib108","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1194\/jlr.M300047-JLR200","article-title":"On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation","volume":"44","author":"Norlin","year":"2003","journal-title":"J Lipid Res"},{"issue":"44","key":"10.1016\/j.pharmr.2026.100115_bib109","doi-asserted-by":"crossref","first-page":"34046","DOI":"10.1074\/jbc.M002663200","article-title":"Oxysterol 7\u03b1-hydroxylase activity by cholesterol 7\u03b1-hydroxylase (CYP7A)","volume":"275","author":"Norlin","year":"2000","journal-title":"J Biol Chem"},{"issue":"3\u20134","key":"10.1016\/j.pharmr.2026.100115_bib110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1357-2725(98)00123-X","article-title":"7-ketocholesterol","volume":"31","author":"Lyons","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib111","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1194\/jlr.M050765","article-title":"Structural characterization of human cholesterol 7\u03b1-hydroxylase","volume":"55","author":"Tempel","year":"2014","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcmgh.2016.10.002","article-title":"Targeting the enterohepatic bile acid signaling induces hepatic autophagy via a CYP7A1-AKT-mTOR axis in mice","volume":"3","author":"Wang","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.pharmr.2026.100115_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154703","article-title":"Targeting mTOR\/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation","volume":"113","author":"Yang","year":"2023","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib114","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3892\/etm.2024.12650","article-title":"Sodium sulphate ameliorates hypercholesterolemia via the upregulation of Cyp7a1 in hepatocytes and alleviates hepatic insulin resistance via the downregulation of Trib3 in mice with high cholesterol diets","volume":"28","author":"Yang","year":"2024","journal-title":"Exp Ther Med"},{"issue":"Pt B","key":"10.1016\/j.pharmr.2026.100115_bib115","article-title":"Mechanism of Bao Gan Ning decoction in attenuating hepatic fibrosis via modulation of the gut microbiome and PPAR\/CYP7A1-mediated bile acid metabolism","volume":"353","author":"Li","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pharmr.2026.100115_bib116","article-title":"To elucidate the effect of Ruanjian Qingmai granules on arteriosclerosis obliterans from the perspective of cholesterol efflux","volume":"12","author":"Jia","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib117","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41401-024-01417-2","article-title":"Branched-chain amino acids promote hepatic Cyp7a1 expression and bile acid synthesis via suppressing FGF21-ERK pathway","volume":"46","author":"Wang","year":"2025","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/ijabmr.ijabmr_165_24","article-title":"Gene expression of Cyp7a1 in liver tissue of type 2 diabetic rats treated with fenugreek and\/or metformin","volume":"15","author":"Garg","year":"2025","journal-title":"Int J Appl Basic Med Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib119","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1172\/JCI112662","article-title":"Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat by inhibiting cholesterol 7 alpha-hydroxylase","volume":"78","author":"Princen","year":"1986","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib120","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.5713\/ab.24.0857","article-title":"Parental betaine supplementation promotes hepatic conversion of cholesterol to bile acids in offspring goslings with epigenetic modulation of CYP7A1 gene","volume":"38","author":"Ma","year":"2025","journal-title":"Anim Biosci"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib121","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002082","article-title":"Interactions between regulatory variants in CYP7A1 (cholesterol 7\u03b1-hydroxylase) promoter and enhancer regions regulate CYP7A1 expression","volume":"11","author":"Wang","year":"2018","journal-title":"Circ Genom Precis Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib122","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/me.2008-0198","article-title":"Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration","volume":"23","author":"Zhang","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib123","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cell.2016.02.023","article-title":"The effect of sustained inflammation on hepatic mevalonate pathway results in hyperglycemia","volume":"165","author":"Okin","year":"2016","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib124","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1172\/JCI10902","article-title":"The bile acid synthetic gene 3\u03b2-hydroxy-\u0394-C-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis","volume":"106","author":"Schwarz","year":"2000","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib125","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1515\/jpem-2024-0454","article-title":"Expanding the genotypic spectrum of 3\u03b2-hydroxy-\u03b45-C27-steroid dehydrogenase (HSD3B7) deficiency: novel mutations and clinical outcomes","volume":"38","author":"Yolda\u015f \u00c7elik","year":"2025","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib126","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1210\/jc.2002-021580","article-title":"Molecular genetics of 3\u03b2-hydroxy-\u03945-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease","volume":"88","author":"Cheng","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmr.2026.100115_bib127","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpba.2016.09.023","article-title":"Bile acid profiles in diabetic (db\/db) mice and their wild type littermates","volume":"131","author":"Chen","year":"2016","journal-title":"J Pharmaceut Biomed Anal"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib128","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.3168\/jds.2023-24485","article-title":"Expression of hepatic genes involved in bile acid metabolism in dairy cows with fatty liver","volume":"107","author":"Du","year":"2024","journal-title":"J Dairy Sci"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100115_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312929","article-title":"Integrated analysis of single-cell and bulk RNA sequencing reveals HSD3B7 as a prognostic biomarker and potential therapeutic target in ccRCC","volume":"25","author":"Liu","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib130","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.913","article-title":"The association between HSD3B7 gene variant and Parkinson\u2019s disease in ethnic Chinese","volume":"8","author":"Lu","year":"2018","journal-title":"Brain Behav"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107945","article-title":"Substrate specificity and kinetic mechanism of 3\u03b2-hydroxy-\u03945-C27-steroid oxidoreductase","volume":"300","author":"Gardner","year":"2024","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib132","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s13023-021-02041-7","article-title":"Genetic spectrum and clinical characteristics of 3\u03b2-hydroxy-\u03945-C27-steroid oxidoreductase (HSD3B7) deficiency in China","volume":"16","author":"Zhao","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib133","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1007\/s10620-020-06722-4","article-title":"Bile acid synthesis disorders in Japan: long-term outcome and chenodeoxycholic acid treatment","volume":"66","author":"Kimura","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib134","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.4081\/pr.2017.7266","article-title":"Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene","volume":"9","author":"Bossi","year":"2017","journal-title":"Pediatr Rep"},{"key":"10.1016\/j.pharmr.2026.100115_bib135","article-title":"Efficacy and safety of switching therapy from chenodeoxycholic acid to cholic acid in Japanese patients with bile acid synthesis disorders","volume":"41","author":"Suzuki","year":"2024","journal-title":"Mol Genet Metab Rep"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib136","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-23-0821","article-title":"Bile acid metabolism mediates cholesterol homeostasis and promotes tumorigenesis in clear cell renal cell carcinoma","volume":"84","author":"Riscal","year":"2024","journal-title":"Cancer Res"},{"issue":"4\u20135","key":"10.1016\/j.pharmr.2026.100115_bib137","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00418-005-0779-0","article-title":"Human sterol 12a-hydroxylase (CYP8B1) is mainly expressed in hepatocytes in a homogenous pattern","volume":"123","author":"Wang","year":"2005","journal-title":"Histochem Cell Biol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib138","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib139","doi-asserted-by":"crossref","first-page":"E418","DOI":"10.1152\/ajpendo.00172.2017","article-title":"Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition","volume":"314","author":"Patankar","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib140","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/HEP.0000000000000627","article-title":"CYP8B1 downregulation mediates the metabolic effects of vertical sleeve gastrectomy in mice","volume":"79","author":"Liu","year":"2024","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib141","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.28689","article-title":"Vertical sleeve gastrectomy activates GPBAR-1\/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice","volume":"64","author":"Ding","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib142","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/21623945.2020.1827519","article-title":"Increased whole body energy expenditure and protection against diet-induced obesity in Cyp8b1-deficient mice is accompanied by altered adipose tissue features","volume":"9","author":"Axling","year":"2020","journal-title":"Adipocyte"},{"issue":"13","key":"10.1016\/j.pharmr.2026.100115_bib143","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.120.045373","article-title":"Insulin prevents hypercholesterolemia by suppressing 12alpha-hydroxylated bile acids","volume":"145","author":"Semova","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib144","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12944-020-1193-2","article-title":"Correlation between 12alpha-hydroxylated bile acids and insulin secretion during glucose tolerance tests in rats fed a high-fat and high-sucrose diet","volume":"19","author":"Yoshitsugu","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib146","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbalip.2003.09.002","article-title":"Gene structure of pig sterol 12alpha-hydroxylase (CYP8B1) and expression in fetal liver: comparison with expression of taurochenodeoxycholic acid 6alpha-hydroxylase (CYP4A21)","volume":"1634","author":"Lundell","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100115_bib147","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152961","article-title":"Haploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humans","volume":"132","author":"Zhong","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmr.2026.100115_bib148","series-title":"Cyp8b1 and uses thereof in therapeutic and diagnostic methods. WIPO (PCT) patent WO2014018375A1","author":"Franchini","year":"2013"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib149","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1152\/ajpendo.00409.2016","article-title":"Cyp8b1 ablation prevents Western diet-induced weight gain and hepatic steatosis because of impaired fat absorption","volume":"313","author":"Bertaggia","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib150","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1096\/fj.201701084RR","article-title":"Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice","volume":"32","author":"Chevre","year":"2018","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib151","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/nu12092598","article-title":"TGR5 signaling in hepatic metabolic health","volume":"12","author":"Holter","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.pharmr.2026.100115_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103290","article-title":"Conjugated secondary 12alpha-hydroxylated bile acids promote liver fibrogenesis","volume":"66","author":"Xie","year":"2021","journal-title":"EBiomedicine"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib153","article-title":"12\u03b1-Hydroxylated bile acid induces hepatic steatosis with dysbiosis in rats","volume":"1865","author":"Lee","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib154","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.pharmr.2026.100115_bib155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100134","article-title":"Low production of 12\u03b1-hydroxylated bile acids prevents hepatic steatosis in Cyp2c70\u2212\/\u2212 mice by reducing fat absorption","volume":"62","author":"Li","year":"2021","journal-title":"J Lipid Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib156","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3390\/biomedicines11123303","article-title":"Decreased FXR agonism in the bile acid pool is associated with impaired FXR signaling in a pig model of pediatric NAFLD","volume":"11","author":"Maj","year":"2023","journal-title":"Biomedicines"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100115_bib157","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.3390\/cells12141888","article-title":"Bile acids, intestinal barrier dysfunction, and related diseases","volume":"12","author":"Shi","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2026.100115_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113136","article-title":"Taurocholic acid, a primary 12\u03b1-hydroxylated bile acid, induces leakiness in the distal small intestine in rats","volume":"165","author":"Liu","year":"2022","journal-title":"Food Chem Toxicol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib159","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.stem.2022.08.008","article-title":"Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib160","doi-asserted-by":"crossref","first-page":"G494","DOI":"10.1152\/ajpgi.00156.2003","article-title":"Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse","volume":"285","author":"Wang","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"30","key":"10.1016\/j.pharmr.2026.100115_bib161","first-page":"2092","article-title":"Association of single nucleotide polymorphism in human CYP8B1 gene with gallstone disease","volume":"91","author":"Qin","year":"2011","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib162","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/jgh.12089","article-title":"Single nucleotide polymorphism rs3732860 in the 3\u2032-untranslated region of CYP8B1 gene is associated with gallstone disease in Han Chinese","volume":"28","author":"Qin","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100712","article-title":"The bile acid chenodeoxycholic acid associates with reduced stroke in humans and mice","volume":"66","author":"Monteiro-Cardoso","year":"2025","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib164","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1124\/dmd.124.001694","article-title":"CYP8B1 catalyzes 12alpha-hydroxylation of C27 bile acid: in vitro conversion of dihydroxycoprostanic acid into trihydroxycoprostanic acid","volume":"52","author":"Wang","year":"2024","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib165","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1007\/s11695-017-2714-6","article-title":"Effects of sleeve gastrectomy on serum 12alpha-hydroxylated bile acids in a diabetic rat model","volume":"27","author":"Wang","year":"2017","journal-title":"Obes Surg"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib166","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1038\/s41401-024-01303-x","article-title":"A new mechanism of thyroid hormone receptor \u03b2 agonists ameliorating nonalcoholic steatohepatitis by inhibiting intestinal lipid absorption via remodeling bile acid profiles","volume":"45","author":"Sun","year":"2024","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib167","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1006\/geno.1998.5606","article-title":"Structure and chromosomal assignment of the sterol 12\u03b1-hydroxylase gene in human and mouse","volume":"56","author":"G\u00e5fvels","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.pharmr.2026.100115_bib168","article-title":"Modulation of cyp8b1 for the prevention and treatment of liver fibrosis and metabolic disorders","volume":"2016","author":"Hayden","year":"2016","journal-title":"WIPO (PCT) patent"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib169","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1515\/hsz-2018-0379","article-title":"Conversion of chenodeoxycholic acid to cholic acid by human CYP8B1","volume":"400","author":"Fan","year":"2019","journal-title":"Biol Chem"},{"key":"10.1016\/j.pharmr.2026.100115_bib170","series-title":"Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease. WIPO patent WO2018034917A1, WIPO (PCT, 2017). US10414775B2 (2019) and EP3496715B1 (2021). patent application WO2018034917A1","author":"Caldwell","year":"2017"},{"key":"10.1016\/j.pharmr.2026.100115_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2021.108952","article-title":"A synthesis of a rationally designed inhibitor of cytochrome P450 8B1, a therapeutic target to treat obesity","volume":"178","author":"Chung","year":"2022","journal-title":"Steroids"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107799","article-title":"Development of a high throughput cytochrome P450 ligand-binding assay","volume":"300","author":"Frydendall","year":"2024","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102344","article-title":"The structure and characterization of human cytochrome P450 8B1 supports future drug design for nonalcoholic fatty liver disease and diabetes","volume":"298","author":"Liu","year":"2022","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib174","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.steroids.2011.01.003","article-title":"Substrate specificity and inhibitor analyses of human steroid 5\u03b2-reductase (AKR1D1)","volume":"76","author":"Chen","year":"2011","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib175","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/er.2018-00089","article-title":"Structural and functional biology of aldo-keto reductase steroid-transforming enzymes","volume":"40","author":"Penning","year":"2019","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib176","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/JOE-21-0280","article-title":"AKR1D1 knockout mice develop a sex-dependent metabolic phenotype","volume":"253","author":"Gathercole","year":"2022","journal-title":"J Endocrinol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib177","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-2007-985073","article-title":"Inborn errors of bile acid metabolism","volume":"27","author":"Heubi","year":"2007","journal-title":"Semin Liver Dis"},{"issue":"35","key":"10.1016\/j.pharmr.2026.100115_bib178","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.3748\/wjg.v24.i35.4086","article-title":"Infant cholestasis patient with a novel missense mutation in the AKR1D1 gene successfully treated by early adequate supplementation with chenodeoxycholic acid: a case report and review of the literature","volume":"24","author":"Wang","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib179","doi-asserted-by":"crossref","DOI":"10.1097\/PG9.0000000000000372","article-title":"Healthy patients with AKR1D1 mutation not requiring primary bile acid therapy: a case series","volume":"4","author":"Kimura","year":"2023","journal-title":"JPGN Rep"},{"key":"10.1016\/j.pharmr.2026.100115_bib180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.metabol.2019.153947","article-title":"AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease","volume":"99","author":"Nikolaou","year":"2019","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib181","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.cmet.2025.01.011","article-title":"AKR1D1 suppresses liver cancer progression by promoting bile acid metabolism-mediated NK cell cytotoxicity","volume":"37","author":"Wei","year":"2025","journal-title":"Cell Metab"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100115_bib182","doi-asserted-by":"crossref","first-page":"16830","DOI":"10.1074\/jbc.M801778200","article-title":"Crystal structure of human liver Delta4-3-ketosteroid 5beta-reductase (AKR1D1) and implications for substrate binding and catalysis","volume":"283","author":"Di Costanzo","year":"2008","journal-title":"J Biol Chem"},{"issue":"51","key":"10.1016\/j.pharmr.2026.100115_bib183","doi-asserted-by":"crossref","first-page":"13537","DOI":"10.1021\/bi801276h","article-title":"Crystal structures of human Delta4-3-ketosteroid 5beta-reductase (AKR1D1) reveal the presence of an alternative binding site responsible for substrate inhibition","volume":"47","author":"Faucher","year":"2008","journal-title":"Biochemistry"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100115_bib184","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.mce.2008.09.013","article-title":"Structure and catalytic mechanism of human steroid 5beta-reductase (AKR1D1)","volume":"301","author":"Di Costanzo","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100115_bib185","doi-asserted-by":"crossref","first-page":"16609","DOI":"10.1074\/jbc.M111.338780","article-title":"Conversion of human steroid 5beta-reductase (AKR1D1) into 3beta-hydroxysteroid dehydrogenase by single point mutation E120H: example of perfect enzyme engineering","volume":"287","author":"Chen","year":"2012","journal-title":"J Biol Chem"},{"issue":"32","key":"10.1016\/j.pharmr.2026.100115_bib186","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1021\/bi800572s","article-title":"The crystal structure of human \u03944-3-ketosteroid 5\u03b2-reductase defines the functional role of the residues of the catalytic tetrad in the steroid double bond reduction mechanism","volume":"47","author":"Faucher","year":"2008","journal-title":"Biochemistry"},{"issue":"30","key":"10.1016\/j.pharmr.2026.100115_bib187","doi-asserted-by":"crossref","first-page":"19786","DOI":"10.1074\/jbc.C109.016931","article-title":"Inhibition of human steroid 5\u03b2-reductase (AKR1D1) by finasteride and structure of the enzyme-inhibitor complex","volume":"284","author":"Drury","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmr.2026.100115_bib188","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.toxlet.2025.02.009","article-title":"Discovery of non-steroidal aldo-keto reductase 1D1 inhibitors through automated screening and in vitro evaluation","volume":"406","author":"K\u0229dzierski","year":"2025","journal-title":"Toxicol Lett"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib189","doi-asserted-by":"crossref","first-page":"G144","DOI":"10.1152\/ajpgi.90515.2008","article-title":"Hepatic bile acid metabolism in the neonatal hamster: expansion of the bile acid pool parallels increased Cyp7a1 expression levels","volume":"297","author":"Burke","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib190","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/biomedicines11051430","article-title":"Successful treatment of a rare cholesterol homeostasis disorder due to CYP27A1 gene mutation with chenodeoxycholic acid therapy","volume":"11","author":"Brlek","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.pharmr.2026.100115_bib191","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsbmb.2019.01.011","article-title":"Mitochondrial oxysterol biosynthetic pathway gives evidence for CYP7B1 as controller of regulatory oxysterols","volume":"189","author":"Kakiyama","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib192","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(02)00157-6","article-title":"Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver","volume":"1588","author":"Matsuzaki","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"30","key":"10.1016\/j.pharmr.2026.100115_bib193","doi-asserted-by":"crossref","first-page":"26804","DOI":"10.1074\/jbc.M202343200","article-title":"Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1","volume":"277","author":"Bj\u00f6rkhem","year":"2002","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib194","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.apsb.2021.05.023","article-title":"Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1","volume":"11","author":"Rizzolo","year":"2021","journal-title":"Acta Pharm Sin B"},{"issue":"3\u20135","key":"10.1016\/j.pharmr.2026.100115_bib195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jsbmb.2011.11.012","article-title":"Metabolism of cholesterol, vitamin D3 and 20-hydroxyvitamin D3 incorporated into phospholipid vesicles by human CYP27A1","volume":"129","author":"Tieu","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib196","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/molecules29050976","article-title":"Involvement of bile acid metabolism and gut microbiota in the amelioration of experimental metabolism-associated fatty liver disease by nobiletin","volume":"29","author":"Xu","year":"2024","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib197","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1007\/s10753-025-02294-5","article-title":"Critical role of cholic acid in the development of iHFC diet-induced MASH in TSNO mice","volume":"48","author":"Goto","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.pharmr.2026.100115_bib198","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fendo.2018.00309","article-title":"Sterol 27-hydroxylase polymorphism significantly associates with shorter telomere, higher cardiovascular and Type-2 diabetes risk in obese subjects","volume":"9","author":"Pavanello","year":"2018","journal-title":"Front Endocrinol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib199","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1641","article-title":"27-hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen","volume":"13","author":"Umetani","year":"2007","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib200","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1038\/s41467-023-39586-z","article-title":"Macrophage-to-endothelial cell crosstalk by the cholesterol metabolite 27HC promotes atherosclerosis in male mice","volume":"14","author":"Yu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100115_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109074","article-title":"The emerging role of 27-hydroxycholesterol in cancer development and progression: an update","volume":"110","author":"Abdalkareem Jasim","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib202","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1158\/0008-5472.CAN-16-2738","article-title":"CYP27A1 loss dysregulates cholesterol homeostasis in prostate cancer","volume":"77","author":"Alfaqih","year":"2017","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib203","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1158\/1055-9965.EPI-18-1083","article-title":"Intratumoral Sterol-27-Hydroxylase (CYP27A1) expression in relation to cholesterol synthesis and vitamin D signaling and its association with lethal prostate cancer","volume":"28","author":"Khan","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib204","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/1541-7786.MCR-19-0974","article-title":"27-hydroxycholesterol impairs plasma membrane lipid raft signaling as evidenced by inhibition of IL6-JAK-STAT3 signaling in prostate cancer cells","volume":"18","author":"Dambal","year":"2020","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.pharmr.2026.100115_bib205","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1251297","article-title":"27-hydroxycholesterol and DNA damage repair: implication in prostate cancer","volume":"13","author":"Galvan","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.pharmr.2026.100115_bib206","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.canlet.2020.08.020","article-title":"27-hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression","volume":"493","author":"Ma","year":"2020","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib207","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat Commun"},{"issue":"8048","key":"10.1016\/j.pharmr.2026.100115_bib208","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/s41586-024-08247-6","article-title":"Liver X receptor unlinks intestinal regeneration and tumorigenesis","volume":"637","author":"Das","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2026.100115_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156392","article-title":"27-hydroxycholesterol exacerbates hepatic insulin resistance via plasma membrane cholesterol remodeling","volume":"173","author":"Yang","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmr.2026.100115_bib210","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15041","article-title":"CYP27A1 deficiency promoted osteoclast differentiation","volume":"11","author":"Fang","year":"2023","journal-title":"PeerJ"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib211","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/cvr\/cvq015","article-title":"Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI","volume":"86","author":"Taylor","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmr.2026.100115_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115649","article-title":"27-hydroxycholesterol impairs learning and memory ability via decreasing brain glucose uptake mediated by the gut microbiota","volume":"168","author":"Hao","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib213","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/molehr\/gax061","article-title":"Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion","volume":"24","author":"Xu","year":"2018","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100486","article-title":"25-hydroxycholesterol in health and diseases","volume":"65","author":"Nguyen","year":"2024","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib215","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.052145","article-title":"The role of 25-hydroxycholesterol in the pathophysiology of brain vessel dysfunction associated with infection and cholesterol dysregulation","volume":"18","author":"Tapia","year":"2025","journal-title":"Dis Model Mech"},{"issue":"29","key":"10.1016\/j.pharmr.2026.100115_bib216","article-title":"Cholesterol 25-hydroxylase protects against diabetic kidney disease by regulating ADP ribosylation factor 4","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"50","key":"10.1016\/j.pharmr.2026.100115_bib217","doi-asserted-by":"crossref","first-page":"32105","DOI":"10.1073\/pnas.2012197117","article-title":"Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion","volume":"117","author":"Zang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"64","key":"10.1016\/j.pharmr.2026.100115_bib218","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb6444","article-title":"Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skin","volume":"6","author":"Takahashi","year":"2021","journal-title":"Sci Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib219","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00428-25","article-title":"Cholesterol 25-hydroxylase inhibits Newcastle disease virus replication by enzyme activity-dependent and direct interaction with nucleocapsid protein","volume":"99","author":"Zhu","year":"2025","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12974-025-03357-y","article-title":"25-hydroxycholesterol modulates microglial function and exacerbates Alzheimer's disease pathology: mechanistic insights and therapeutic potential of cholesterol esterification inhibition","volume":"22","author":"Choi","year":"2025","journal-title":"J Neuroinflammation"},{"issue":"40","key":"10.1016\/j.pharmr.2026.100115_bib221","first-page":"37004","article-title":"From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans","volume":"276","author":"Bjorkhem","year":"2001","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib222","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj1354","article-title":"CYP46A1-mediated cholesterol turnover induces sex-specific changes in cognition and counteracts memory loss in ovariectomized mice","volume":"10","author":"Latorre-Leal","year":"2024","journal-title":"Sci Adv"},{"issue":"25","key":"10.1016\/j.pharmr.2026.100115_bib223","doi-asserted-by":"crossref","first-page":"22980","DOI":"10.1074\/jbc.M303415200","article-title":"Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover","volume":"278","author":"Lund","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib224","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1073858414568122","article-title":"24(S)-hydroxycholesterol as a modulator of neuronal signaling and survival","volume":"22","author":"Sun","year":"2016","journal-title":"Neuroscientist"},{"key":"10.1016\/j.pharmr.2026.100115_bib225","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib226","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease","volume":"139","author":"Boussicault","year":"2016","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib227","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/brain\/awv166","article-title":"CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease","volume":"138","author":"Djelti","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib228","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40478-025-02054-4","article-title":"Astrocyte-neuron combined targeting for CYP46A1 gene therapy in Huntington's disease","volume":"13","author":"Parsai","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib229","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002974","article-title":"The cholesterol 24-hydroxylase CYP46A1 promotes \u03b1-synuclein pathology in Parkinson's disease","volume":"23","author":"Dai","year":"2025","journal-title":"PLOS Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib230","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.70001","article-title":"Sterol imbalances and cholesterol-24-hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis","volume":"35","author":"Griffiths","year":"2025","journal-title":"Brain Pathol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib231","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/epi.18287","article-title":"A review of the putative antiseizure and antiepileptogenic mechanisms of action for soticlestat","volume":"66","author":"Kondo","year":"2025","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib232","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13059-015-0690-5","article-title":"Statistically based splicing detection reveals neural enrichment and tissue-specific induction of circular RNA during human fetal development","volume":"16","author":"Szabo","year":"2015","journal-title":"Genome Biol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib233","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm6494","article-title":"Gene losses in the common vampire bat illuminate molecular adaptations to blood feeding","volume":"8","author":"Blumer","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.pharmr.2026.100115_bib234","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1477009","article-title":"SNPs in cytochromes P450 catalyzing cholesterol degradation in brain are associated with Parkinson's disease","volume":"15","author":"Petkova-Kirova","year":"2024","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib235","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3390\/biomedicines13092132","article-title":"Identification of key biomarkers related to lipid metabolism in acute pancreatitis and their regulatory mechanisms based on bioinformatics and machine learning","volume":"13","author":"Zhang","year":"2025","journal-title":"Biomedicines"},{"issue":"38","key":"10.1016\/j.pharmr.2026.100115_bib236","doi-asserted-by":"crossref","first-page":"E4006","DOI":"10.1073\/pnas.1413561111","article-title":"Genetic, anatomic, and clinical determinants of human serum sterol and vitamin D levels","volume":"111","author":"Stiles","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pharmr.2026.100115_bib237","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5175581","article-title":"Downregulation of CYP39A1 serves as a novel biomarker in hepatocellular carcinoma with worse clinical outcome","volume":"2021","author":"Li","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib238","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1136\/gutjnl-2021-326050","article-title":"Blocking hepatocarcinogenesis by a cytochrome P450 family member with female-preferential expression","volume":"71","author":"Ji","year":"2022","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib239","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0022-2275(20)32094-0","article-title":"Structure and functions of human oxysterol 7\u03b1-hydroxylase cDNAs and gene","volume":"40","author":"Wu","year":"1999","journal-title":"J Lipid Res"},{"issue":"22","key":"10.1016\/j.pharmr.2026.100115_bib240","doi-asserted-by":"crossref","first-page":"16536","DOI":"10.1074\/jbc.M001811200","article-title":"Disruption of the oxysterol 7alpha-hydroxylase gene in mice","volume":"275","author":"Li-Hawkins","year":"2000","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib241","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1194\/jlr.RA120000924","article-title":"Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition","volume":"61","author":"Kakiyama","year":"2020","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib242","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100363","article-title":"Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver disease","volume":"64","author":"Minowa","year":"2023","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100757","article-title":"Liver specific transgenic expression of CYP7B1 attenuates early western diet-induced MASLD progression","volume":"66","author":"Kakiyama","year":"2025","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib244","doi-asserted-by":"crossref","first-page":"G747","DOI":"10.1152\/ajpgi.00024.2024","article-title":"StarD5 levels of expression correlate with onset and progression of steatosis and liver fibrosis","volume":"326","author":"Kakiyama","year":"2024","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib245","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1172\/JCI2962","article-title":"Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease","volume":"102","author":"Setchell","year":"1998","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib246","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/lt.22331","article-title":"Successful heterozygous living donor liver transplantation for an oxysterol 7alpha-hydroxylase deficiency in a Japanese patient","volume":"17","author":"Mizuochi","year":"2011","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib247","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10545-014-9695-6","article-title":"Liver disease in infancy caused by oxysterol 7 alpha-hydroxylase deficiency: successful treatment with chenodeoxycholic acid","volume":"37","author":"Dai","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib248","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.3390\/cells10102656","article-title":"Oxysterol 7-\u03b1 hydroxylase (CYP7B1) attenuates metabolic-associated fatty liver disease in mice at thermoneutrality","volume":"10","author":"Evangelakos","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2026.100115_bib249","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.836741","article-title":"Cold-induced lipoprotein clearance in Cyp7b1-deficient mice","volume":"10","author":"Evangelakos","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib250","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/jpet.102.033553","article-title":"Effect of hyperinsulinemia and type 2 diabetes-like hyperglycemia on expression of hepatic cytochrome P450 and glutathione S-transferase isoforms in a New Zealand obese-derived mouse backcross population","volume":"302","author":"Pass","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmr.2026.100115_bib251","first-page":"A15888","article-title":"Elevations in the cholesterol metabolite 27-hydroxycholesterol cause insulin resistance in mice","volume":"128","author":"Barrera","year":"2013","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib252","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1210\/en.2017-00288","article-title":"Attenuated effects of bile acids on glucose metabolism and insulin sensitivity in a male mouse model of prenatal undernutrition","volume":"158","author":"Ma","year":"2017","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib253","doi-asserted-by":"crossref","first-page":"G232","DOI":"10.1152\/ajpgi.00153.2025","article-title":"Inhibition of SREBP-1c rescues hepatic CYP7B1 expression and bile acid synthesis in malnourished mice","volume":"329","author":"Wan","year":"2025","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib254","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgae334","article-title":"CYP7B1 deficiency impairs myeloid cell activation in autoimmune disease of the central nervous system","volume":"3","author":"Song","year":"2024","journal-title":"PNAS Nexus"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0318822","article-title":"Differential expression and modulation of EBI2 and 7\u03b1,25-OHC synthesizing (CH25H, CYP7B1) and degrading (HSD3B7) enzymes in mouse and human brain vascular cells","volume":"20","author":"Caratis","year":"2025","journal-title":"PLOS One"},{"issue":"7743","key":"10.1016\/j.pharmr.2026.100115_bib256","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-0920-1","article-title":"The CH25H-CYP7B1-ROR\u03b1 axis of cholesterol metabolism regulates osteoarthritis","volume":"566","author":"Choi","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib257","doi-asserted-by":"crossref","first-page":"245","DOI":"10.14348\/molcells.2023.2149","article-title":"7\u03b1,25-Dihydroxycholesterol-Induced Oxiapoptophagic chondrocyte death via the modulation of p53-Akt-mTOR axis in osteoarthritis pathogenesis","volume":"46","author":"Seo","year":"2023","journal-title":"Mol Cells"},{"key":"10.1016\/j.pharmr.2026.100115_bib258","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fphar.2015.00060","article-title":"7\u03b1, 25-dihydroxycholesterol-mediated activation of EBI2 in immune regulation and diseases","volume":"6","author":"Sun","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharmr.2026.100115_bib259","article-title":"MicroRNA-10a-3p improves cartilage degeneration by regulating CH25H-CYP7B1-RORalpha mediated cholesterol metabolism in knee osteoarthritis rats","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12957-024-03504-4","article-title":"Association of CYP7B1 expression with the prognosis of endometrial cancer: a retrospective study","volume":"22","author":"Lu","year":"2024","journal-title":"World J Surg Oncol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib261","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.3390\/ijms25094762","article-title":"CYP7B1 as a biomarker for prostate cancer risk and progression: metabolic and oncogenic signatures (diagnostic immunohistochemistry analysis by tissue microarray in prostate cancer patients-diamond study)","volume":"25","author":"Russo","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib262","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.chembiol.2024.01.009","article-title":"CYP7B1-mediated 25-hydroxycholesterol degradation maintains quiescence-activation balance and improves therapeutic potential of mesenchymal stem cells","volume":"31","author":"Zhang","year":"2024","journal-title":"Cell Chem Biol"},{"issue":"42","key":"10.1016\/j.pharmr.2026.100115_bib263","doi-asserted-by":"crossref","first-page":"28485","DOI":"10.1074\/jbc.R109.042168","article-title":"CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions","volume":"284","author":"Stiles","year":"2009","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib264","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/febs.12733","article-title":"Human steroid and oxysterol 7alpha-hydroxylase CYP7B1: substrate specificity, azole binding and misfolding of clinically relevant mutants","volume":"281","author":"Yantsevich","year":"2014","journal-title":"FEBS J"},{"key":"10.1016\/j.pharmr.2026.100115_bib265","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157172","article-title":"Celastrol ameliorates metabolic dysfunction associated steatohepatitis by regulating the CYP7B1-mediated alternative bile acid synthetic pathway","volume":"147","author":"Hu","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib266","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108670","article-title":"Inhibition of 7\u03b1,26-dihydroxycholesterol biosynthesis promotes midbrain dopaminergic neuron development","volume":"27","author":"Hennegan","year":"2024","journal-title":"Iscience"},{"issue":"suppl 1","key":"10.1016\/j.pharmr.2026.100115_bib267","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1182\/blood-2024-211675","article-title":"Enhancing hematopoietic stem and progenitor cell mobilization with 27-hydroxycholesterol and Cyp7b1 inhibitors","volume":"144","author":"Vu","year":"2024","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib268","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10545-011-9416-3","article-title":"Bile acid-CoA ligase deficiency--a new inborn error of bile acid metabolism","volume":"35","author":"Chong","year":"2012","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib269","article-title":"Loss of SLC27A5 activates hepatic stellate cells and promotes liver fibrosis via unconjugated cholic acid","volume":"11","author":"Wu","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib270","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1194\/jlr.R049437","article-title":"Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades","volume":"55","author":"Hofmann","year":"2014","journal-title":"J Lipid Res"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100115_bib271","doi-asserted-by":"crossref","first-page":"10227","DOI":"10.1016\/S0021-9258(18)99213-6","article-title":"Purification and characterization of bile acid-CoA:amino acid N-acyltransferase from human liver","volume":"266","author":"Johnson","year":"1991","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib272","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/hep.21528","article-title":"Human and rat bile acid-CoA:amino acid N-acyltransferase are liver-specific peroxisomal enzymes: implications for intracellular bile salt transport","volume":"45","author":"Pellicoro","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib273","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/hep.23954","article-title":"Unconjugated bile salts shuttle through hepatocyte peroxisomes for taurine conjugation","volume":"52","author":"Rembacz","year":"2010","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib274","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100361","article-title":"Identification of bile acid-CoA:amino acid N-acyltransferase as the hepatic N-acyl taurine synthase for polyunsaturated fatty acids","volume":"64","author":"Trammell","year":"2023","journal-title":"J Lipid Res"},{"issue":"5 suppl","key":"10.1016\/j.pharmr.2026.100115_bib275","doi-asserted-by":"crossref","first-page":"66S","DOI":"10.1002\/hep.1840040812","article-title":"Bile acids and bile salts: ionization and solubility properties","volume":"4","author":"Carey","year":"1984","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib276","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ng1147","article-title":"Complex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT","volume":"34","author":"Carlton","year":"2003","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib277","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/hep4.2041","article-title":"Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in mice","volume":"6","author":"Alrehaili","year":"2022","journal-title":"Hepatol Commun"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib278","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1093\/gbe\/evz238","article-title":"Evolutionary analysis of bile acid-conjugating enzymes reveals a complex duplication and reciprocal loss history","volume":"11","author":"Kirilenko","year":"2019","journal-title":"Genome Biol Evol"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib279","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100297","article-title":"Baat gene knockout alters post-natal development, the gut microbiome, and reveals unusual bile acids in mice","volume":"63","author":"Neugebauer","year":"2022","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib280","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1053\/j.gastro.2006.02.012","article-title":"Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity","volume":"130","author":"Hubbard","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib281","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-025-58649-x","article-title":"Balance between bile acid conjugation and hydrolysis activity can alter outcomes of gut inflammation","volume":"16","author":"Fu","year":"2025","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib282","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.19.01307","article-title":"Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, Phase III trial","volume":"38","author":"Finn","year":"2020","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib283","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S1470-2045(20)30156-X","article-title":"Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study","volume":"21","author":"Lee","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib284","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","article-title":"Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib285","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2007.02.030","article-title":"Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma","volume":"150","author":"Scheimann","year":"2007","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib286","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mrrev.2004.08.001","article-title":"Bile acids as carcinogens in human gastrointestinal cancers","volume":"589","author":"Bernstein","year":"2005","journal-title":"Mutat Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib287","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib288","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","article-title":"Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer","volume":"36","author":"Ma","year":"2019","journal-title":"Cancer Cell"},{"issue":"6730","key":"10.1016\/j.pharmr.2026.100115_bib289","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1126\/science.adl4100","article-title":"Bile acid synthesis impedes tumor-specific T cell responses during liver cancer","volume":"387","author":"Varanasi","year":"2025","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib290","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.gastro.2013.02.004","article-title":"Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency","volume":"144","author":"Setchell","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib291","first-page":"348","article-title":"For debate: should bariatric surgery be performed in children and adolescents with hypothalamic obesity?","volume":"14","author":"Stolbova","year":"2017","journal-title":"Pediatr Endocrinol Rev"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib292","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3201\/eid2405.151435","article-title":"Transmission of severe fever with thrombocytopenia syndrome virus by Haemaphysalis longicornis ticks, China","volume":"24","author":"Zhuang","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100115_bib293","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib294","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41564-022-01279-6","article-title":"Akkermansia muciniphila protects mice against an emerging tick-borne viral pathogen","volume":"8","author":"Xie","year":"2023","journal-title":"Nat Microbiol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib295","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.chom.2023.05.026","article-title":"Intestinal mucus and their glycans: a habitat for thriving microbiota","volume":"31","author":"Luis","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib296","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2021.08.047","article-title":"The tight junction protein ZO-1 is dispensable for barrier function but critical for effective mucosal repair","volume":"161","author":"Kuo","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib297","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2356284","article-title":"Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis","volume":"16","author":"Pan","year":"2024","journal-title":"Gut Microbes"},{"issue":"Pt 1","key":"10.1016\/j.pharmr.2026.100115_bib298","article-title":"Enhancing the specific activity of 3\u03b1-hydroxysteroid dehydrogenase through cross-regional combinatorial mutagenesis","volume":"283","author":"Ma","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.pharmr.2026.100115_bib299","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fmolb.2020.00153","article-title":"Current knowledge on the function of alpha-methyl acyl-CoA racemase in human diseases","volume":"7","author":"Kong","year":"2020","journal-title":"Front Mol Biosci"},{"issue":"40","key":"10.1016\/j.pharmr.2026.100115_bib300","doi-asserted-by":"crossref","first-page":"11289","DOI":"10.1073\/pnas.1613228113","article-title":"ACOX2 deficiency: a disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment","volume":"113","author":"Vilarinho","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib301","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2172671","article-title":"Bile acids as modulators of gut microbiota composition and function","volume":"15","author":"Larabi","year":"2023","journal-title":"Gut Microbes"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib302","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J Lipid Res"},{"issue":"7961","key":"10.1016\/j.pharmr.2026.100115_bib303","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41586-023-05989-7","article-title":"Profiling the human intestinal environment under physiological conditions","volume":"617","author":"Shalon","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib304","first-page":"1676","article-title":"Effects of several bile acids on the production of virulence factors by Pseudomonas aeruginosa","volume":"14","author":"Lomri","year":"2024","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib305","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41522-024-00566-w","article-title":"Effects of bile acids on the growth, composition and metabolism of gut bacteria","volume":"10","author":"Peng","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib306","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/microbiolres15030085","article-title":"Exploring the antibacterial potential of bile salts: inhibition of biofilm formation and cell growth in Pseudomonas aeruginosa and Staphylococcus aureus","volume":"15","author":"Tyagi","year":"2024","journal-title":"Microbiol Res"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib307","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.3390\/cells11111734","article-title":"Making sense of quorum sensing at the intestinal mucosal interface","volume":"11","author":"Uhlig","year":"2022","journal-title":"Cells"},{"issue":"877","key":"10.1016\/j.pharmr.2026.100115_bib308","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1098\/rspb.1947.0029","article-title":"Studies on the antibacterial properties of the bile acids and some compounds derived from cholanic acid","volume":"134","author":"Stacey","year":"1947","journal-title":"Proc R Soc Lond B Biol Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib309","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/JB.188.5.1979-1986.2006","article-title":"Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria","volume":"188","author":"Kurdi","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.pharmr.2026.100115_bib310","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fmicb.2017.01581","article-title":"In vitro antibacterial activity of unconjugated and conjugated bile salts on Staphylococcus aureus","volume":"8","author":"Sannasiddappa","year":"2017","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib311","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/microorganisms11071823","article-title":"The mechanism of antimicrobial activity of conjugated bile acids against lactic acid bacilli","volume":"11","author":"Chai","year":"2023","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib312","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","article-title":"The interaction between bacteria and bile","volume":"29","author":"Begley","year":"2005","journal-title":"FEMS Microbiol Rev"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib313","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.3390\/microorganisms10091792","article-title":"Bile acids: major regulator of the gut microbiome","volume":"10","author":"An","year":"2022","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib314","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib315","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/19490976.2020.1732268","article-title":"The microbiome modulating activity of bile acids","volume":"11","author":"Tian","year":"2020","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib316","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3390\/microorganisms10102025","article-title":"Eggerthella lenta DSM 2243 alleviates bile acid stress response in Clostridium ramosum and Anaerostipes caccae by transformation of bile acids","volume":"10","author":"Pedersen","year":"2022","journal-title":"Microorganisms"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib317","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/19490976.2020.1712983","article-title":"Virulence gene repression promotes Listeria monocytogenes systemic infection","volume":"11","author":"Pombinho","year":"2020","journal-title":"Gut Microbes"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib318","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1046\/j.1365-2958.2003.03531.x","article-title":"Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein","volume":"48","author":"Rosenberg","year":"2003","journal-title":"Mol Microbiol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib319","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1073\/pnas.1115621109","article-title":"Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection","volume":"109","author":"Fanning","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 6","key":"10.1016\/j.pharmr.2026.100115_bib320","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1099\/mic.0.038307-0","article-title":"DnaK from Bifidobacterium animalis subsp. lactis is a surface-exposed human plasminogen receptor upregulated in response to bile salts","volume":"156","author":"Candela","year":"2010","journal-title":"Microbiology (Reading)"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib321","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib322","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib323","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.cell.2024.02.019","article-title":"The underappreciated diversity of bile acid modifications","volume":"187","author":"Mohanty","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib324","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.128","article-title":"Taxonomic identification of bile salt hydrolase-encoding lactobacilli: modulation of the enterohepatic bile acid profile","volume":"2","author":"Song","year":"2023","journal-title":"Imeta"},{"issue":"Suppl 2","key":"10.1016\/j.pharmr.2026.100115_bib325","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.2337\/dc09-S355","article-title":"Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration","volume":"32","author":"Staels","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib326","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.apsb.2015.01.001","article-title":"Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids","volume":"5","author":"Ferrebee","year":"2015","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib327","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.chom.2025.04.020","article-title":"Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: function, mechanism, and therapeutic prospects","volume":"33","author":"Luo","year":"2025","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib328","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1854008","article-title":"The gut bacterium Extibacter muris produces secondary bile acids and influences liver physiology in gnotobiotic mice","volume":"13","author":"Streidl","year":"2021","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib329","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cell.2021.12.035","article-title":"Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome","volume":"185","author":"Jin","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib330","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41575-024-00896-2","article-title":"Another renaissance for bile acid gastrointestinal microbiology","volume":"21","author":"Ridlon","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib331","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02475-17","article-title":"Targeted synthesis and characterization of a gene cluster encoding NAD(P)H-dependent 3\u03b1-, 3\u03b2-, and 12\u03b1-Hydroxysteroid dehydrogenases from Eggerthella CAG:298, a gut metagenomic sequence","volume":"84","author":"Mythen","year":"2018","journal-title":"Appl Environ Microbiol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib332","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00235-18","article-title":"Metabolism of oxo-bile acids and characterization of recombinant 12\u03b1-Hydroxysteroid dehydrogenases from bile acid 7\u03b1-Dehydroxylating human gut bacteria","volume":"84","author":"Doden","year":"2018","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib333","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12866-024-03433-y","article-title":"Strain-dependent induction of primary bile acid 7-dehydroxylation by cholic acid","volume":"24","author":"Vico-Oton","year":"2024","journal-title":"BMC Microbiol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib334","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.chom.2021.07.013","article-title":"A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1","volume":"29","author":"Li","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib335","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/JLB.1MA0122-513R","article-title":"Synthesis and identification of lithocholic acid 3-sulfate as ROR\u03b3t ligand to inhibit Th17 cell differentiation","volume":"112","author":"Xiao","year":"2022","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib336","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41564-023-01570-0","article-title":"Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids","volume":"9","author":"Liu","year":"2024","journal-title":"Nat Microbiol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib337","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.cell.2024.03.034","article-title":"Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway","volume":"187","author":"Nie","year":"2024","journal-title":"Cell"},{"issue":"8000","key":"10.1016\/j.pharmr.2026.100115_bib338","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41586-023-06990-w","article-title":"Bile salt hydrolase catalyses formation of amine-conjugated bile acids","volume":"626","author":"Rimal","year":"2024","journal-title":"Nature"},{"issue":"8000","key":"10.1016\/j.pharmr.2026.100115_bib339","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41586-024-07017-8","article-title":"Bile salt hydrolase acyltransferase activity expands bile acid diversity","volume":"626","author":"Guzior","year":"2024","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100115_bib340","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1016\/j.cell.2025.07.017","article-title":"Identification of gut microbial bile acid metabolic enzymes via an AI-assisted pipeline","volume":"188","author":"Ding","year":"2025","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib341","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/1040841X.2023.2262020","article-title":"Bile acid and its bidirectional interactions with gut microbiota: a review","volume":"50","author":"He","year":"2024","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.pharmr.2026.100115_bib342","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","article-title":"Interactions between gut bacteria and bile in health and disease","volume":"56","author":"Long","year":"2017","journal-title":"Mol Aspects Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib343","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"issue":"36","key":"10.1016\/j.pharmr.2026.100115_bib344","doi-asserted-by":"crossref","first-page":"13580","DOI":"10.1073\/pnas.0804437105","article-title":"Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome","volume":"105","author":"Jones","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib345","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/apt.16676","article-title":"Review article: insights into the bile acid-gut microbiota axis in intestinal failure-associated liver disease-redefining the treatment approach","volume":"55","author":"Wang","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib346","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hep.30661","article-title":"Enhanced microbial bile acid deconjugation and impaired ileal uptake in pregnancy repress intestinal regulation of bile acid synthesis","volume":"70","author":"Ovadia","year":"2019","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib347","doi-asserted-by":"crossref","first-page":"M622","DOI":"10.1111\/j.1750-3841.2011.02431.x","article-title":"All 4 bile salt hydrolase proteins are responsible for the hydrolysis activity in Lactobacillus plantarum ST-III","volume":"76","author":"Ren","year":"2011","journal-title":"J Food Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib348","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10529-013-1434-9","article-title":"Cloning and analysis of bile salt hydrolase genes from Lactobacillus plantarum CGMCC No. 8198","volume":"36","author":"Gu","year":"2014","journal-title":"Biotechnol Lett"},{"issue":"Pt 12","key":"10.1016\/j.pharmr.2026.100115_bib349","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1099\/00221287-147-12-3403","article-title":"Genes encoding bile salt hydrolases and conjugated bile salt transporters in Lactobacillus johnsonii 100\u2013100 and other Lactobacillus species","volume":"147","author":"Elkins","year":"2001","journal-title":"Microbiology (Reading)"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib350","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3168\/jds.S0022-0302(04)73164-1","article-title":"Purification and characterization of three different types of bile salt hydrolases from Bifidobacterium strains","volume":"87","author":"Kim","year":"2004","journal-title":"J Dairy Sci"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100115_bib351","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1021\/bi0473206","article-title":"Conjugated bile acid hydrolase is a tetrameric N-terminal thiol hydrolase with specific recognition of its cholyl but not of its tauryl product","volume":"44","author":"Rossocha","year":"2005","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib352","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4315\/0362-028X-64.5.725","article-title":"Bile salt hydrolase activity of Enterococci isolated from food: screening and quantitative determination","volume":"64","author":"Franz","year":"2001","journal-title":"J Food Prot"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib353","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.4315\/0362-028X-67.12.2772","article-title":"Cloning of the bile salt hydrolase (bsh) gene from Enterococcus faecium FAIR-E 345 and chromosomal location of bsh genes in food enterococci","volume":"67","author":"Wijaya","year":"2004","journal-title":"J Food Prot"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib354","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1046\/j.1365-2958.2002.03080.x","article-title":"Listeria monocytogenes bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis","volume":"45","author":"Dussurget","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.pharmr.2026.100115_bib355","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fmed.2017.00163","article-title":"Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts","volume":"4","author":"Urdaneta","year":"2017","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib356","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3390\/microorganisms9061122","article-title":"Bile salt hydrolases: at the crossroads of microbiota and human health","volume":"9","author":"Bourgin","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib357","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","article-title":"Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome","volume":"7","author":"Song","year":"2019","journal-title":"Microbiome"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib358","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/nu15081850","article-title":"Emerging roles of gut microbial modulation of bile acid composition in the etiology of cardiovascular diseases","volume":"15","author":"Yntema","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib359","doi-asserted-by":"crossref","first-page":"13","DOI":"10.17221\/299\/2014-CJFS","article-title":"Two different methods for screening of bile salt hydrolase activity in Lactobacillus strains","volume":"33","author":"Sedl\u00e1\u010dkov\u00e1","year":"2015","journal-title":"Czech J Food Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib360","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/IAI.00952-06","article-title":"A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice","volume":"75","author":"Delpino","year":"2007","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib361","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib362","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1124\/mol.116.106617","article-title":"Orally administered berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal FXR signaling pathway","volume":"91","author":"Sun","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib363","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41401-022-00921-7","article-title":"Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity","volume":"44","author":"Zhong","year":"2023","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib364","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/hep.30975","article-title":"Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib365","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.chom.2024.06.008","article-title":"Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification","volume":"32","author":"Shen","year":"2024","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib366","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/19476337.2021.1914176","article-title":"Effect of bile salt hydrolase-active Lactobacillus plantarum Y15 on high cholesterol diet induced hypercholesterolemic mice","volume":"19","author":"Liu","year":"2021","journal-title":"CyTA J Food"},{"key":"10.1016\/j.pharmr.2026.100115_bib367","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1513541","article-title":"New insights into microbial bile salt hydrolases: from physiological roles to potential applications","volume":"16","author":"Dong","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.pharmr.2026.100115_bib368","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib369","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41419-020-02974-0","article-title":"The triterpenoid sapogenin (2\u03b1-OH-protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR\/GLP-1 axis through gut microbiota remodelling","volume":"11","author":"Xie","year":"2020","journal-title":"Cell Death Dis"},{"issue":"Pt 3","key":"10.1016\/j.pharmr.2026.100115_bib370","article-title":"An insoluble cellulose nanofiber with robust expansion capacity protects against obesity","volume":"277","author":"Yu","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib371","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/s42255-024-01072-1","article-title":"Ketogenic diet-induced bile acids protect against obesity through reduced calorie absorption","volume":"6","author":"Li","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.pharmr.2026.100115_bib372","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155938","article-title":"Shengmai San formula alleviates high-fat diet-induced obesity in mice through gut microbiota-derived bile acid promotion of M2 macrophage polarization and thermogenesis","volume":"133","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"43","key":"10.1016\/j.pharmr.2026.100115_bib373","doi-asserted-by":"crossref","first-page":"73501","DOI":"10.18632\/oncotarget.18113","article-title":"An extract from the Atlantic brown algae Saccorhiza polyschides counteracts diet-induced obesity in mice via a gut related multi-factorial mechanisms","volume":"8","author":"Huebbe","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib374","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/metabo10110475","article-title":"Anti-adipogenic effect of Theabrownin is mediated by bile acid alternative synthesis via gut microbiota remodeling","volume":"10","author":"Kuang","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.pharmr.2026.100115_bib375","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.29219\/fnr.v64.3751","article-title":"Bile salt hydrolase-overexpressing Lactobacillus strains can improve hepatic lipid accumulation in vitro in an NAFLD cell model","volume":"64","author":"Huang","year":"2020","journal-title":"Food Nutr Res"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100115_bib376","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.1323599111","article-title":"Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut","volume":"111","author":"Joyce","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib377","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1039\/D1FO00260K","article-title":"Lactiplantibacillus plantarum H-87 prevents high-fat diet-induced obesity by regulating bile acid metabolism in C57BL\/6J mice","volume":"12","author":"Liang","year":"2021","journal-title":"Food Funct"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib378","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13020-024-01021-w","article-title":"Zhi-Kang-Yin formula attenuates high-fat diet-induced metabolic disorders through modulating gut microbiota-bile acids axis in mice","volume":"19","author":"Li","year":"2024","journal-title":"Chin Med"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib379","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.261","article-title":"Gut Bifidobacterium pseudocatenulatum protects against fat deposition by enhancing secondary bile acid biosynthesis","volume":"3","author":"Zha","year":"2024","journal-title":"Imeta"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib380","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1007\/s11427-025-3014-6","article-title":"Christensenella tenuis alleviates endotoxemia and metabolic disorders via inhibition of intestinal lipopolysaccharide translocation","volume":"68","author":"Jiang","year":"2025","journal-title":"Sci China Life Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib381","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1079\/BJN19980030","article-title":"Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity","volume":"79","author":"De Smet","year":"1998","journal-title":"Br J Nutr"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100115_bib382","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1017\/S0007114511004703","article-title":"Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults","volume":"107","author":"Jones","year":"2012","journal-title":"Br J Nutr"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib383","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ejcn.2012.126","article-title":"Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial","volume":"66","author":"Jones","year":"2012","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib384","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1039\/C8FO02181C","article-title":"Cholesterol-lowering potentials of Lactobacillus strain overexpression of bile salt hydrolase on high cholesterol diet-induced hypercholesterolemic mice","volume":"10","author":"Wang","year":"2019","journal-title":"Food Funct"},{"key":"10.1016\/j.pharmr.2026.100115_bib385","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2024.106357","article-title":"Bile salt hydrolase: the complexity behind its mechanism in relation to lowering-cholesterol lactobacilli probiotics","volume":"120","author":"Agolino","year":"2024","journal-title":"J Funct Foods"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib386","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1039\/D1FO03143K","article-title":"Cholesterol-lowering effect of bile salt hydrolase from a Lactobacillus johnsonii strain mediated by FXR pathway regulation","volume":"13","author":"Zhu","year":"2022","journal-title":"Food Funct"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib387","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1039\/D3FO04871C","article-title":"Cholesterol lowering in diet-induced hypercholesterolemic mice using Lactobacillus bile salt hydrolases with different substrate specificities","volume":"15","author":"Zhao","year":"2024","journal-title":"Food Funct"},{"key":"10.1016\/j.pharmr.2026.100115_bib388","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.617676","article-title":"Lactobacillus delbrueckii interfere with bile acid enterohepatic circulation to regulate cholesterol metabolism of growing-finishing pigs via its bile salt hydrolase activity","volume":"7","author":"Hou","year":"2020","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib389","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1038\/s41467-019-12896-x","article-title":"Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism","volume":"10","author":"Huang","year":"2019","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib390","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.biotechadv.2017.12.005","article-title":"Importance of microbial defence systems to bile salts and mechanisms of serum cholesterol reduction","volume":"36","author":"Hor\u00e1\u010dkov\u00e1","year":"2018","journal-title":"Biotechnol Adv"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib391","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41589-020-0467-3","article-title":"Development of a covalent inhibitor of gut bacterial bile salt hydrolases","volume":"16","author":"Adhikari","year":"2020","journal-title":"Nat Chem Biol"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100115_bib392","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201800728","article-title":"Bile salt hydrolase and S-layer protein are the key factors affecting the hypocholesterolemic activity of Lactobacillus casei-fermented milk in hamsters","volume":"62","author":"Guo","year":"2018","journal-title":"Mol Nutr Food Res"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib393","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3390\/ijms11062499","article-title":"Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings","volume":"11","author":"Ooi","year":"2010","journal-title":"Int J Mol Sci"},{"issue":"1783","key":"10.1016\/j.pharmr.2026.100115_bib394","first-page":"15","article-title":"Diagnosis and treatment of gallstone disease","volume":"259","author":"Lee","year":"2015","journal-title":"Practitioner"},{"issue":"30","key":"10.1016\/j.pharmr.2026.100115_bib395","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","article-title":"Gut microbiota, inflammatory bowel disease and colorectal cancer","volume":"28","author":"Quaglio","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib396","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41467-023-36089-9","article-title":"Bile salt hydrolase in non-enterotoxigenic Bacteroides potentiates colorectal cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100115_bib397","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3390\/nu14153212","article-title":"Bile salt hydrolase-competent probiotics in the management of IBD: unlocking the \"bile acid code\"","volume":"14","author":"Gadaleta","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib398","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2379566","article-title":"Bacteroides fragilis alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway","volume":"16","author":"Chen","year":"2024","journal-title":"Gut Microbes"},{"issue":"42","key":"10.1016\/j.pharmr.2026.100115_bib399","doi-asserted-by":"crossref","first-page":"23233","DOI":"10.1021\/acs.jafc.4c03617","article-title":"Discovery of tetrahydro tanshinone I as a naturally occurring covalent pan-inhibitor against gut microbial bile salt hydrolases","volume":"72","author":"Zhang","year":"2024","journal-title":"J Agric Food Chem"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib400","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1039\/D1FO03277A","article-title":"Discovery and characterization of amentoflavone as a naturally occurring inhibitor against the bile salt hydrolase produced by Lactobacillus salivarius","volume":"13","author":"Li","year":"2022","journal-title":"Food Funct"},{"key":"10.1016\/j.pharmr.2026.100115_bib401","series-title":"Identification of Bile Salt Hydrolase Inhibitors, the Promising Alternative to Antibiotic Growth Promoters to Enhance Animal Production","author":"Smith","year":"2013"},{"issue":"7797","key":"10.1016\/j.pharmr.2026.100115_bib402","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41586-020-2047-9","article-title":"Global chemical effects of the microbiome include new bile-acid conjugations","volume":"579","author":"Quinn","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib403","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhammer","year":"2019","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib404","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/03602532.2023.2248680","article-title":"Pregnane X receptor as a therapeutic target for cholestatic liver injury","volume":"55","author":"Lan","year":"2023","journal-title":"Drug Metab Rev"},{"issue":"7813","key":"10.1016\/j.pharmr.2026.100115_bib405","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib406","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100392","article-title":"The Hylemon-Bj\u00f6rkhem pathway of bile acid 7-dehydroxylation: history, biochemistry, and microbiology","volume":"64","author":"Ridlon","year":"2023","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib407","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2323233","article-title":"BaiJ and BaiB are key enzymes in the chenodeoxycholic acid 7\u03b1-dehydroxylation pathway in the gut microbe Clostridium scindens ATCC 35704","volume":"16","author":"Meibom","year":"2024","journal-title":"Gut Microbes"},{"issue":"1\u20132","key":"10.1016\/j.pharmr.2026.100115_bib408","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbalip.2007.10.008","article-title":"Clostridium scindens baiCD and baiH genes encode stereo-specific 7alpha\/7beta-hydroxy-3-oxo-delta4-cholenoic acid oxidoreductases","volume":"1781","author":"Kang","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib409","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00455-22","article-title":"Identification and characterization of major bile acid 7\u03b1-dehydroxylating bacteria in the human gut","volume":"7","author":"Kim","year":"2022","journal-title":"mSystems"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib410","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1194\/jlr.M020313","article-title":"Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7\u03b1-dehydroxylating intestinal bacterium","volume":"53","author":"Ridlon","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharmr.2026.100115_bib411","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuaf016","article-title":"Clostridium scindens: history and current outlook for a keystone species in the mammalian gut involved in bile acid and steroid metabolism","volume":"49","author":"Daniel","year":"2025","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib412","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.anaerobe.2009.05.004","article-title":"Isolation and characterization of a bile acid inducible 7alpha-dehydroxylating operon in Clostridium hylemonae TN271","volume":"16","author":"Ridlon","year":"2010","journal-title":"Anaerobe"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib413","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00039-20","article-title":"Strain-dependent inhibition of Clostridioides difficile by commensal Clostridia carrying the bile acid-inducible (bai) operon","volume":"202","author":"Reed","year":"2020","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib414","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular physiology of bile acid signaling in health, disease, and aging","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib415","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1084\/jem.20171965","article-title":"Bile acids in glucose metabolism in health and disease","volume":"215","author":"Shapiro","year":"2018","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib416","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4093\/dmj.2019.0043","article-title":"Understanding bile acid signaling in diabetes: from pathophysiology to therapeutic targets","volume":"43","author":"Ferrell","year":"2019","journal-title":"Diabetes Metab J"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib417","article-title":"Bile acids contribute to the development of non-alcoholic steatohepatitis in mice","volume":"4","author":"Gillard","year":"2022","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib418","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1124\/dmd.121.000643","article-title":"Molecular regulation of bile acid homeostasis","volume":"50","author":"Choudhuri","year":"2022","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib419","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15698\/cst2021.01.239","article-title":"Improving glucose and lipids metabolism: drug development based on bile acid related targets","volume":"5","author":"Shen","year":"2021","journal-title":"Cell Stress"},{"issue":"34","key":"10.1016\/j.pharmr.2026.100115_bib420","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo2794","article-title":"Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury","volume":"8","author":"Li","year":"2022","journal-title":"Sci Adv"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib421","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i8.107453","article-title":"Deoxycholic acid induces reactive oxygen species accumulation and promotes colorectal cancer cell apoptosis through the CaMKII-Ca2+ pathway","volume":"17","author":"Chen","year":"2025","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib422","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","article-title":"Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8+ T cell effector functions","volume":"57","author":"Cong","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib423","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41467-021-27758-8","article-title":"Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion","volume":"13","author":"Hu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100115_bib424","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s40104-019-0391-0","article-title":"Heat stress affects fecal microbial and metabolic alterations of primiparous sows during late gestation","volume":"10","author":"He","year":"2019","journal-title":"J Anim Sci Biotechnol"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib425","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s11739-023-03343-3","article-title":"The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease","volume":"18","author":"Di Ciaula","year":"2023","journal-title":"Intern Emerg Med"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib426","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/prot.24971","article-title":"Structure and functional characterization of a bile acid 7\u03b1 dehydratase BaiE in secondary bile acid synthesis","volume":"84","author":"Bhowmik","year":"2016","journal-title":"Proteins"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib427","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1128\/jb.174.7.2065-2071.1992","article-title":"The bile acid-inducible baiB gene from Eubacterium sp. strain VPI 12708 encodes a bile acid-coenzyme A ligase","volume":"174","author":"Mallonee","year":"1992","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib428","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/microorganisms9030469","article-title":"Microbial hydroxysteroid dehydrogenases: from alpha to omega","volume":"9","author":"Doden","year":"2021","journal-title":"Microorganisms"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib429","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1194\/jlr.M039834","article-title":"Contribution of the 7\u03b2-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon","volume":"54","author":"Lee","year":"2013","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib430","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nchembio.1864","article-title":"A biosynthetic pathway for a prominent class of microbiota-derived bile acids","volume":"11","author":"Devlin","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib431","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1907271","article-title":"Completion of the gut microbial epi-bile acid pathway","volume":"13","author":"Doden","year":"2021","journal-title":"Gut Microbes"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib432","first-page":"523","article-title":"Bile acid oxidation by Eggerthella lenta strains C592 and DSM 2243T","volume":"9","author":"Harris","year":"2018","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib433","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41396-022-01333-5","article-title":"Genome-centric investigation of bile acid metabolizing microbiota of dairy cows and associated diet-induced functional implications","volume":"17","author":"Lin","year":"2023","journal-title":"ISME J"},{"key":"10.1016\/j.pharmr.2026.100115_bib434","article-title":"Gut microbiota and bile acids: metabolic interactions and impacts on diabetic kidney disease","volume":"7","author":"Liu","year":"2024","journal-title":"Curr Res Microb Sci"},{"key":"10.1016\/j.pharmr.2026.100115_bib435","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1371574","article-title":"Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"15","author":"Mao","year":"2024","journal-title":"Front Pharmacol"},{"issue":"15","key":"10.1016\/j.pharmr.2026.100115_bib436","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512123","article-title":"The potential of bile acids as biomarkers for metabolic disorders","volume":"24","author":"Yin","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib437","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12964-025-02299-5","article-title":"Common mechanisms of Gut microbe-based strategies for the treatment of intestine-related diseases: based on multi-target interactions with the intestinal barrier","volume":"23","author":"Chen","year":"2025","journal-title":"Cell Commun Signal"},{"issue":"7809","key":"10.1016\/j.pharmr.2026.100115_bib438","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2026.100115_bib439","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106340","article-title":"Sequence and structure-guided discovery of a novel NADH-dependent 7\u03b2-hydroxysteroid dehydrogenase for efficient biosynthesis of ursodeoxycholic acid","volume":"131","author":"Huang","year":"2023","journal-title":"Bioorg Chem"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib440","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/catal13060965","article-title":"The impact of bilirubin on 7\u03b1- and 7\u03b2-Hydroxysteroid dehydrogenases: spectra and docking analysis","volume":"13","author":"Ji","year":"2023","journal-title":"Catalysts"},{"issue":"37","key":"10.1016\/j.pharmr.2026.100115_bib441","doi-asserted-by":"crossref","first-page":"41712","DOI":"10.1021\/acsami.2c10322","article-title":"Enhanced oral absorption and liver distribution of polymeric nanoparticles through traveling the enterohepatic circulation pathways of bile acid","volume":"14","author":"Wang","year":"2022","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib442","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0004563218817798","article-title":"Bile acids and the metabolic syndrome","volume":"56","author":"McGlone","year":"2019","journal-title":"Ann Clin Biochem"},{"issue":"6704","key":"10.1016\/j.pharmr.2026.100115_bib443","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1126\/science.adq2341","article-title":"Breaking boundaries: bacteria act as architects of host T cell modulators using bile acids","volume":"385","author":"Yao","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2026.100115_bib444","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105808","article-title":"The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies","volume":"207","author":"Nikolaou","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pharmr.2026.100115_bib445","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2014.12.003","article-title":"Promiscuity and diversity in 3-ketosteroid reductases","volume":"151","author":"Penning","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib446","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.3390\/microorganisms11112730","article-title":"The role of gut microbiota-derived lithocholic acid, deoxycholic acid and their derivatives on the function and differentiation of immune cells","volume":"11","author":"Kiriyama","year":"2023","journal-title":"Microorganisms"},{"issue":"7885","key":"10.1016\/j.pharmr.2026.100115_bib447","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","article-title":"Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians","volume":"599","author":"Sato","year":"2021","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib448","doi-asserted-by":"crossref","first-page":"E1397","DOI":"10.1210\/jc.2014-1395","article-title":"5\u03b1-reductase type 1 modulates insulin sensitivity in men","volume":"99","author":"Upreti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmr.2026.100115_bib449","article-title":"Incidence of type 2 diabetes mellitus in men receiving steroid 5\u03b1-reductase inhibitors: population based cohort study","volume":"365","author":"Wei","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib450","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2337\/db14-0249","article-title":"5\u03b1-reductase type 1 deficiency or inhibition predisposes to insulin resistance, hepatic steatosis, and liver fibrosis in rodents","volume":"64","author":"Livingstone","year":"2015","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib451","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170960","article-title":"Differential feedback regulation of \u03944-3-Oxosteroid 5\u03b2-reductase expression by bile acids","volume":"12","author":"Valanejad","year":"2017","journal-title":"PLOS One"},{"key":"10.1016\/j.pharmr.2026.100115_bib452","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107775","article-title":"Novel microbially transformed bile acids: biosynthesis, structure, and function","volume":"216","author":"Zhao","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharmr.2026.100115_bib453","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1127743","article-title":"Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity","volume":"14","author":"Su","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib454","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.steroids.2007.12.001","article-title":"Human Delta4\u20133-oxosteroid 5\u03b2-reductase (AKR1D1) deficiency and steroid metabolism","volume":"73","author":"Palermo","year":"2008","journal-title":"Steroids"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100115_bib455","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.3390\/ijms25168857","article-title":"5\u03b2-dihydrosteroids: formation and properties","volume":"25","author":"Penning","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib456","doi-asserted-by":"crossref","first-page":"313","DOI":"10.21037\/tau-22-58","article-title":"The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2022","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib457","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2132903","article-title":"Formation of secondary allo-bile acids by novel enzymes from gut Firmicutes","volume":"14","author":"Lee","year":"2022","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib458","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1038\/s41467-025-61425-6","article-title":"Identification of gut bacteria reductases that biotransform steroid hormones","volume":"16","author":"Arp","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100115_bib459","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1093420","article-title":"The 7-\u03b1-dehydroxylation pathway: an integral component of gut bacterial bile acid metabolism and potential therapeutic target","volume":"13","author":"Wise","year":"2023","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib460","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41589-023-01526-9","article-title":"Host-microbiome orchestration of the sulfated metabolome","volume":"20","author":"D'Agostino","year":"2024","journal-title":"Nat Chem Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib461","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.chom.2020.12.004","article-title":"A microbial metabolite remodels the gut-liver axis following bariatric surgery","volume":"29","author":"Chaudhari","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"91","key":"10.1016\/j.pharmr.2026.100115_bib462","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade6924","article-title":"Sulfated bile acid is a host-derived ligand for MAIT cells","volume":"9","author":"Ito","year":"2024","journal-title":"Sci Immunol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib463","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41564-022-01176-y","article-title":"A biosynthetic pathway for the selective sulfonation of steroidal metabolites by human gut bacteria","volume":"7","author":"Yao","year":"2022","journal-title":"Nat Microbiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib464","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41589-020-0604-z","article-title":"Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects","volume":"17","author":"Chaudhari","year":"2021","journal-title":"Nat Chem Biol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100115_bib465","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/ph13090222","article-title":"Nonalcoholic fatty liver disease (NAFLD) and hepatic cytochrome P450 (CYP) enzymes","volume":"13","author":"Jamwal","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100115_bib466","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","article-title":"A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures","volume":"5","author":"Govaere","year":"2023","journal-title":"Nat Metab"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib467","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2021.12.006","article-title":"Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation","volume":"28","author":"Thibaut","year":"2022","journal-title":"Trends Mol Med"},{"issue":"746","key":"10.1016\/j.pharmr.2026.100115_bib468","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk8198","article-title":"MRGPRX4 mediates phospho-drug-associated pruritus in a humanized mouse model","volume":"16","author":"Chien","year":"2024","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib469","doi-asserted-by":"crossref","DOI":"10.1093\/lifemeta\/loae023","article-title":"Protecting liver health with microbial-derived succinylated bile acids","volume":"3","author":"Demagny","year":"2024","journal-title":"Life Metab"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib470","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.molmed.2024.06.003","article-title":"3-O-acylated bile acids: disrupters or harmonizers of metabolism?","volume":"31","author":"Chen","year":"2025","journal-title":"Trends Mol Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib471","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.243","article-title":"Novel microbial modifications of bile acids and their functional implications","volume":"3","author":"Zheng","year":"2024","journal-title":"Imeta"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib472","first-page":"802","article-title":"Novel approaches in glucose and lipid metabolism disorder therapy: targeting the gut microbiota-bile acid axis","volume":"14","author":"Jiang","year":"2025","journal-title":"Biology (Basel)"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib473","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/metabo15060401","article-title":"Bile acids and type 2 diabetes: roles in glucose homeostasis and therapeutic opportunities","volume":"15","author":"Lin","year":"2025","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100115_bib474","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/ph17081015","article-title":"Bacteroides uniformis ameliorates carbohydrate and lipid metabolism disorders in diabetic mice by regulating bile acid metabolism via the gut\u2013liver axis","volume":"17","author":"Zhu","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100115_bib475","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.cell.2024.04.020","article-title":"A microbial-derived succinylated bile acid to safeguard liver health","volume":"187","author":"Perino","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib476","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-024-00914-3","article-title":"The changing metabolic landscape of bile acids - keys to metabolism and immune regulation","volume":"21","author":"Mohanty","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib477","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40168-024-01750-y","article-title":"Microbiota-derived indoles alleviate intestinal inflammation and modulate microbiome by microbial cross-feeding","volume":"12","author":"Wang","year":"2024","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib478","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12934-025-02662-8","article-title":"Lactobacillus gasseri LGV03-derived indole-3-lactic acid ameliorates immune response by activating aryl hydrocarbon receptor","volume":"24","author":"Zhang","year":"2025","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.pharmr.2026.100115_bib479","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1341938","article-title":"Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions","volume":"15","author":"Wei","year":"2024","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100115_bib480","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000484","article-title":"Gut microbial metabolites in MASLD: implications of mitochondrial dysfunction in the pathogenesis and treatment","volume":"8","author":"Zhang","year":"2024","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100115_bib481","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","article-title":"Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8+ T cell immunity","volume":"35","author":"Zhang","year":"2023","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100115_bib482","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/nutrit\/nuad042","article-title":"Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis","volume":"82","author":"Pham","year":"2024","journal-title":"Nutr Rev"},{"key":"10.1016\/j.pharmr.2026.100115_bib483","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116791","article-title":"When short-chain fatty acids meet type 2 diabetes mellitus: revealing mechanisms, envisioning therapies","volume":"233","author":"Xie","year":"2025","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib484","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12964-023-01219-9","article-title":"Short-chain fatty acids in diseases","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib485","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2414796","article-title":"The effects of gut microbiota on appetite regulation and the underlying mechanisms","volume":"16","author":"Yu","year":"2024","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100115_bib486","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s44324-025-00066-1","article-title":"Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes","volume":"3","author":"Jyoti","year":"2025","journal-title":"NPJ Metab Health Dis"},{"key":"10.1016\/j.pharmr.2026.100115_bib487","doi-asserted-by":"crossref","DOI":"10.3389\/fchbi.2024.1389620","article-title":"An activity-based probe for antimicrobial target DXP synthase, a thiamin diphosphate-dependent enzyme","volume":"3","author":"Coco","year":"2024","journal-title":"Front Chem Biol"},{"key":"10.1016\/j.pharmr.2026.100115_bib488","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107483","article-title":"Targeting gut microbiota as a therapeutic target in T2DM: a review of multi-target interactions of probiotics, prebiotics, postbiotics, and synbiotics with the intestinal barrier","volume":"210","author":"Chen","year":"2024","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100115_bib489","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/S0022-2275(20)35353-0","article-title":"Polydeoxycholate in human and hamster feces: a major product of cholate metabolism","volume":"34","author":"Benson","year":"1993","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100115_bib490","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/biom12050687","article-title":"Production of new microbially conjugated bile acids by human gut microbiota","volume":"12","author":"Garcia","year":"2022","journal-title":"Biomolecules"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100115_bib491","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1074\/jbc.R116.767434","article-title":"Glucuronides in the gut: sugar-driven symbioses between microbe and host","volume":"292","author":"Pellock","year":"2017","journal-title":"J Biol Chem"},{"issue":"7998","key":"10.1016\/j.pharmr.2026.100115_bib492","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41586-023-06906-8","article-title":"Reverse metabolomics for the discovery of chemical structures from humans","volume":"626","author":"Gentry","year":"2024","journal-title":"Nature"},{"issue":"Web Server issue","key":"10.1016\/j.pharmr.2026.100115_bib493","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkn201","article-title":"NCBI BLAST: a better web interface","volume":"36","author":"Johnson","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"8016","key":"10.1016\/j.pharmr.2026.100115_bib494","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100115_bib495","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41592-025-02593-7","article-title":"Rapid and sensitive protein complex alignment with Foldseek-multimer","volume":"22","author":"Kim","year":"2025","journal-title":"Nat Methods"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:57:57Z","timestamp":1777442277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":495,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0031699726000037"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100115","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100115"}}